KG - King Pharmaceuticals, Inc.

Profile for King Pharmaceuticals Inc. (KG)

After Hours: $ 8.575

-0.045 (-0.52%)

Volume: 38.7 k

6:07 PM EST Nov 21, 2008

Business Description:
A pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products.

Address:

501 Fifth Street, Bristol, TN 37620

Telephone:

(423) 989-8000

Website:

www.kingpharm.com

Facsimile:

(423) 989-8711

Email:

Details

CEO:

Brian A. Markison

Employees:

2050

Market Cap:

2.12 b

Issue Type:

Common Stock

Auditor:

PRICEWATERHOUSECOOPERS LLP

Last Audit:

Unqualified

Indices:

DJ US Pharmaceuticals, Drug Manufacturers - Other, Russell 1000, S&P 1500 Pharmaceuticals Index, S&P 500 Pharmaceuticals Index, S&P 900 Pharmaceuticals Index, S&P Composite

Industry Classifications

Sector:

Healthcare

CIK:

0001047699

Industry:

Drugs

NAICS:

Pharmaceutical Preparation Manufacturing (325412)

QM ID:

Drug Manufacturers - Other (511)

SIC:

Pharmaceutical Preparations (2834)

Profitability

Management Effectiveness

Gross Margin:

71.90

Return on Equity:

5.00

EBIT Margin:

9.80

Return on Capital:

4.40

Profit Margin:

9.40

Return on Assets:

3.80

Share Statistics

Outstanding:

246.49 m

Float:

245.01 m

Short Interest:

7.58 m (as of 10/28/08)

Short Int Ratio:

2.50

% of Float:

3.10%

Non-Corp. Insider Hold'gs:

0.60% (as of 9/1/08)

Bought Prev 3 Mo:

Sold Prev 3 Mo:

Institution Hold'gs:

99.60% (as of 10/1/08)

Total Held:

245.57 m

Institutions:

391

Bought Prev Mo:

16.81 m

Sold Prev Mo:

19.55 m